Appraising relative and excess mortality in population-based studies of chronic diseases such as end-stage renal disease

Clinical Epidemiology

Volumn 3, Issue 1, 2011, Pages 157-169

  Elie, Caroline ^a   de Rycke, Y ^b   Jais, J P ^a   Landais, P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT CURIE   (France)

Author keywords

Additive hazard model; Cox model; Expected mortality; Generalized linear model; Multiplicative hazard model

Indexed keywords

AGE; AGED; ANALYTIC METHOD; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MORTALITY; POPULATION RESEARCH; RELATIVE MORTALITY; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE; THERAPY EFFECT;

EID: 79958023061     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S17349     Document Type: Article

References (38)

1. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244-256.
2. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389-2430.
3. Perneger TV, Klag MJ, Whelton PK. Cause of death in patients with end-stage renal disease: death certificates vs registry reports. Am J Public Health. 1993;83(12):1735-1738.
4. Li SQ, Cass A, Cunningham J. Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reports. Aust N Z J Public Health. 2003;27(4):419-424.
5. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101-121.
6. Therneau TM, Offord J. Expected Survival Based on Hazard Rates (Update). Rochester, Minnesota: Department of Health Science Research, Mayo Clinic; 1999.
7. Therneau TM, Grambsch PM. Expected survival. In: Modeling Survival Data. Extending the Cox Model. New York: Springer; 2000:261-287.
8. Verheul HA, Dekker E, Bossuyt P, et al. Background mortality in clinical survival studies. Lancet. 1993;341(8849):872-875.
9. Giorgi R, Hedelin G, Schaffer P. Relative survival: comparison of regressive models and advice for the user. J Epidemiol Biostat. 2001;6(6):455-462.
10. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51-64.
11. Breslow N, Lubin P, Marek P, Langholz B. Multiplicative models and cohort analysis. JASA. 1983;78:1-12.
12. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume II- The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer Scientific Publications No. 82; 1987.
13. Buckley JD. Additive and multiplicative models for relative survival rates. Biometrics. 1984;40(1):51-62.
14. Andersen PK, Vaeth M. Simple parametric and nonparametric models for excess and relative mortality. Biometrics. 1989;45(2):523-535.
15. Andersen PK, Borch-Johnsen K, Deckert T, et al. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics. 1985;41(4):921-932.
16. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8(9): 773-783.
17. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8(9):784-796.
18. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-756.
19. Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63(2):213-221.
20. Mani K, Bjorck M, Lundkvist J, Wanhainen A. Improved long-term survival after abdominal aortic aneurysm repair. Circulation. 2009; 120(3): 201-211.
21. Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513-521.
22. Ekstrom M, Franklin KA, Strom KE. Increased relative mortality in women with severe oxygen-dependent COPD. Chest. 2010;137(1): 31-36.
23. Landais P, Simonet A, Guillon D, et al. SIMS REIN: a multi-source information system for end-stage renal disease. C R Biol. 2002;325(4): 515-528.
24. Couchoud C, Stengel B, Landais P, et al. The Renal Epidemiology and Information Network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant. 2006;21(2):411-418.
25. Martinussen T, Scheike TH. Dynamic Regression Models for Survival Data. New York: Springer-Verlag; 2006.
26. Pohar M, Stare J. Relative survival analysis in R. Comput Methods Programs Biomed. 2006;81(3):272-278.
27. Mc Cullagh P, Nelder JA. Generalized Linear Models. 2nd ed. London: Chapman and Hall; 1989.
28. Stare J, Pohar M, Henderson R. Goodness of fit of relative survival models. Stat Med. 2005;24(24):3911-3925.
29. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
30. Aalen OO. A model for non-parametric regression analysis of counting processes. Lecture Notes on Mathematical Statistics and Probability. Klonecki W, Kozek A, Rosiski J, editors. Vol 2. New York: Springer- Verlag; 1980:1-25.
31. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Applied Statistics. 1987;36(3):309-317.
32. Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med. 1990;9(5):529-538.
33. Cortese G, Scheike TH. Dynamic regression hazards models for relative survival. Stat Med. 2008;27(18):3563-3584.
34. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35(3):747-756.
35. Favier O, Heutte N, Stamatoullas-Bastard A, et al. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer. 2009;115(8):1680-1691.
36. Reulen RC, Winter DL, Frobisher C, et al. Long-term causespecific mortality among survivors of childhood cancer. JAMA. 2010;304(2):172-179.
37. van Dijk PC, Zwinderman AH, Dekker FW, et al. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int. 2007;71(1):53-59.
38. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol. 2007;18(7):2125-2134.